U.S. markets close in 2 hours 8 minutes

EyePoint Pharmaceuticals, Inc. (EYPT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
9.04-0.04 (-0.44%)
As of 1:48PM EDT. Market open.
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
As of Date: 4/18/2021
Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 7

Trading Information

Stock Price History

Beta (5Y Monthly) 1.35
52-Week Change 34.37%
S&P500 52-Week Change 352.13%
52 Week High 315.06
52 Week Low 33.50
50-Day Moving Average 310.41
200-Day Moving Average 38.09

Share Statistics

Avg Vol (3 month) 3346.03k
Avg Vol (10 day) 3246.2k
Shares Outstanding 528.74M
Implied Shares Outstanding 6N/A
Float 19.89M
% Held by Insiders 110.97%
% Held by Institutions 133.20%
Shares Short (Mar 30, 2021) 4660.68k
Short Ratio (Mar 30, 2021) 42.19
Short % of Float (Mar 30, 2021) 42.70%
Short % of Shares Outstanding (Mar 30, 2021) 42.30%
Shares Short (prior month Feb 25, 2021) 4381.74k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Dec 08, 2020
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Dec 08, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2020


Profit Margin -131.82%
Operating Margin (ttm)-106.57%

Management Effectiveness

Return on Assets (ttm)-27.86%
Return on Equity (ttm)-337.87%

Income Statement

Revenue (ttm)34.44M
Revenue Per Share (ttm)2.68
Quarterly Revenue Growth (yoy)-17.40%
Gross Profit (ttm)11.19M
EBITDA -34.05M
Net Income Avi to Common (ttm)-45.39M
Diluted EPS (ttm)-3.54
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)44.91M
Total Cash Per Share (mrq)1.56
Total Debt (mrq)41.06M
Total Debt/Equity (mrq)221.48
Current Ratio (mrq)4.24
Book Value Per Share (mrq)1.02

Cash Flow Statement

Operating Cash Flow (ttm)-14.44M
Levered Free Cash Flow (ttm)-14.44M